OXCARBAZEPINE

Generic: OXCARBAZEPINE

NorthStar RxLLCManufacturer
ORALRoute
OXCARBAZEPINEActive Substance
2023-10-20Original Approval

OXCARBAZEPINE is FDA application ANDA216749, sponsored by HETERO LABS LTD III. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
1,891 reports
2
SEIZURE
1,326 reports
3
OFF LABEL USE
1,099 reports
4
DRUG INTERACTION
691 reports
5
DIZZINESS
685 reports
6
FATIGUE
663 reports
7
FALL
597 reports
8
HYPONATRAEMIA
592 reports
9
SOMNOLENCE
567 reports
10
NAUSEA
554 reports